The Centers for Disease Control and Prevention has recommended that wider use be made of a new meningitis vaccine known as Menactra and manufactured by Sanofi Pasteur. The following categories of young people are the ones the CDC is most interested in seeing vaccinated: all 11- and 12-year-olds; high school freshmen or children under 15, whichever comes earlier, and college freshmen living in dormitories.
Each year about 3,000 people in the United States contract meningococcal disease. About 10% of these people die and another 15% may suffer serious permanent disabilities including loss of hearing, brain damage, or the loss of a limb. .
Personal Injury & Side Effects News
<You can leave a response, or trackback from your own site.
